Metabolic Effects of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir
In a small randomized trial, nondiabetic lopinavir/r users with at least one metabolic complication experienced significantly better improvements on several metabolic parameters if they switched to ritonavir-boosted atazanavir than if they did not switch.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)